Algen originated from the laboratory of UC Berkeley Professor
AlgenCRISPR is a proprietary, next-generation CRISPR system developed by Algen. Our best-in-class technology offers robust, fine-tuned and precise gene modulation to deconvolute complex biology. AlgenCRISPR powers the AlgenBrain platform to industrialize single-cell, combinatorial gene modulation driving towards impactful human-centric therapeutic endpoints.
Algen’s proprietary deep learning models are built on billions of real-time, dynamic gene expression changes that occur throughout disease progression. Our unique expertise is essential to handle the enormous, complex human-centric datasets and multi hundred-thousand gene modulated cell fates we generate to illuminate disease-driving RNA signaling pathways and extract the most important insights for drug discovery.
Discover More About Algen Bio
Algen to present at the inaugural J.P. Morgan Asset Management: Life Sciences Innovation Summit 2024
CEO and Co-Founder Chun-Hao Huang presents at Biotech Showcase 2024 during JPM week
Algen presents innovation in using CRISPR/AI to uncover disease-driving RNA messages for therapeutics discovery at Discovery on Target 2023
Algen unveils AlgenBrain platform at BIO International Convention 2023
Algen debuts at Y Combinator’s Summer 2021 Demo Day
Illumina Accelerator announces eighth investment cycle
